跳至主要内容
临床试验/JPRN-UMIN000028855
JPRN-UMIN000028855招募中2 期

Development of a new transcranial magnetic stimulation therapy for treatment-resistant depression and identification of its predictor of response - Development of a new form of rTMS treatment for TRD

Department of Neuropsychiatry, Keio University School of Medicine0 个研究点目标入组 150 人开始时间: 2018年1月19日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Persons with cerebral organic diseases (e.g., intracranial organic lesions of moderate severity or higher, neurodegenerative diseases, etc.) (2) History of convulsive seizures or epilepsy (3) Substance-related disorders in the past 6 months (4) Serious or unstable physical illness (5) Undergone rTMS treatment or ECT within the past 6 months (6) Any contraindication to TMS or MRI procedures such as metal implants, pacemakers, claustrophobia, etc. (7) Patients whose head, neck, or body size is not suitable for MRI scanner (8) Other cases that the principal investigator and subinvestigators deem inappropriate as research subjects

研究者

发起方
Department of Neuropsychiatry, Keio University School of Medicine

相似试验